BeiGene Announces Initiation of First Pivotal Study in China of PD-1 Antibody BGB-A317
Apr 21, 2017 11:00 am UTC| Business
BEIJING, April 21, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced that the first...
Apr 21, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., April 21, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
NewLink Genetics Announces Presentation of Two Abstracts at ASCO
Apr 21, 2017 11:00 am UTC| Business
AMES, Iowa, April 21, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported that two abstracts will...
Sera Prognostics is Named a 2017 Silver Edison Award Winner
Apr 21, 2017 11:00 am UTC| Business
NEW YORK, April 21, 2017 -- The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced today that Sera Prognostics’ PreTRM Test...
Apr 21, 2017 11:00 am UTC| Business
CHAPEL HILL, N.C., April 21, 2017 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious...
Crown Crafts to Present at The 21st Annual BURKENROAD REPORTS Investment Conference
Apr 21, 2017 10:45 am UTC| Business
GONZALES, La., April 21, 2017 -- Crown Crafts, Inc. (NASDAQ:CRWS) (the “Company”) announced today that E. Randall Chestnut, Chairman, President and Chief Executive Officer; Olivia W. Elliott, Vice President and Chief...
Apr 21, 2017 10:30 am UTC| Business
WEST PALM BEACH, Fla., April 21, 2017 -- Ocwen Financial Corporation (NYSE:OCN) (Ocwen or the Company) today issued the following statement in response to receiving cease and desist orders from state mortgage regulators...